Imprinted genes are expressed either from the paternal or the maternal allele, because the other allele has been silenced in the mother's or father's germline. Imprints are characterized by DNA methylation at cytosine phosphate guanine sites. Recently, abnormal sperm parameters and male infertility have been linked to aberrant methylation patterns of imprinted genes in sperm DNA. However, these studies did not account for possible epigenetic heterogeneity in sperm. We have investigated whether spermatozoa are a homogeneous cell population regarding DNA methylation of imprinted genes. Swim-up sperm was obtained from 45 men with normal (n = 19) and abnormal (n = 26) sperm parameters. DNA methylation of the imprinted gene KCNQ1OT1 was measured in multiple pools of 10 spermatozoa by a highly sensitive pyrosequencing-based oligo-sperm methylation assay (OSMA). DNA methylation of four imprinted genes (KCNQ1OT1, MEST, H19 and MEG3) was further analysed by deep bisulfite sequencing, which allows analysis at the single-cell level. Using OSMA, we found a significantly increased variation in the DNA methylation values of the maternally methylated gene KCNQ1OT1 in samples with abnormal sperm parameters. DBS showed that normozoospermic samples had a homogenous pattern of DNA methylation, whereas oligoasthenozoospermic samples contained discrete populations of spermatozoa with either normal or abnormal methylation patterns. Aberrant methylation of H19 appears to occur preferentially on the maternally inherited allele. Our results demonstrate the presence of epigenetic mosaicism in the semen of oligoasthenozoospermic men, which probably results from errors in imprint erasure.
Introduction
Epigenetic regulation of gene expression occurs mainly through modification of histones and methylation of cytosines at cytosine phosphate guanine (CpG) dinucleotides. DNA hypermethylation at regulatory regions is generally associated with gene silencing while hypomethylation usually results in gene expression (1) . DNA methylation is extremely important for a process known as genetic imprinting, which takes place in the germline of placental mammals. Regulatory regions of imprinted genes are methylated either in oocytes or in sperm, resulting in their expression exclusively from one parental allele. Paternally imprinted genes are methylated in sperm (and therefore unmethylated in the oocyte) and only the maternal copy is expressed in the offspring (2) . In a similar way, maternally imprinted genes are unmethylated in sperm and methylated in the oocyte, resulting in the expression of the paternal allele in the offspring. Thus, in contrast to other genes, imprinted genes are typically expressed from one allele only. Many imprinted genes are involved in the regulation of growth and behaviour. Decreased or increased levels of their activity lead to a group of recognizable syndromes called imprinting diseases, which include Prader-Willi Syndrome (PWS), Beckwith-Wiedemann Syndrome (BWS) and others (3) . Pathomechanisms include chromosomal deletions and duplications, uniparental disomy (i.e. the presence of two copies of a chromosome from the same parent), gene mutations and imprinting defects (i.e. the presence of a maternal imprint on a paternal chromosome or vice versa).
After fertilization, the genome of the newly formed embryo undergoes a wave of demethylation which removes most of the epigenetic marks from the parental genomes except at imprinted genes and transposable repetitive elements (e.g. LINEs), which are protected from this process (4) . After implantation, primordial germ cells (PGCs) undergo a second wave of demethylation, this time involving imprinting erasure, after which new, gametespecific imprints are established by de novo methylation (5-7), a process that can occur at different times on the paternal and maternal alleles (5, 6, 8, 9) .
Infertility affects about 15% of couples, with half of the cases linked to a male factor. About 30% of infertile and 13.3% of azoospermic men have a diagnosis of idiopathic infertility (10) . In recent years, epigenetic factors in sperm have been indicated as potentially linked to male infertility (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) . Several publications have reported an association of aberrant imprinting with abnormal sperm parameters, such as reduced sperm count or defective morphology (11) (12) (13) (14) (15) (16) (17) (18) . These studies have measured the average methylation levels of a gene in samples containing a large number (over a million) of sperm cells and did not account for possible heterogeneity in DNA methylation, which can only be evaluated, ideally, at the single-sperm level. Although DNA methylation measurements in spermatozoa are usually performed following swim-up and therefore avoid contamination by other cell types, sperm itself is at many levels a highly heterogeneous cell population, for example regarding morphology, biochemistry and DNA biology (22, 23) . So far, however, the level of intra-individual epigenetic variability has not been studied in sperm. Therefore, it remains unknown whether the abnormal methylation levels are caused by epimutations at random CpG sites in the genome of each sperm or by the existence of sperm cell populations with normal and abnormal imprints, respectively. We aimed at understanding whether the epigenetic defects found in some infertile men are due to random epimutations affecting different CpG dinucleotides in different spermatozoa or due to discrete sperm populations with different patterns of cytosine methylation. We have addressed this question with two novel techniques: oligo-sperm methylation assay (OSMA) and deep bisulfite sequencing (DBS). The data presented herein indicate that the aberrant DNA methylation levels of imprinted genes found in some men with abnormal sperm parameters are a result of the existence of a subpopulation of spermatozoa carrying incorrect imprints.
Results

Increased DNA methylation variability in infertile patients
We have developed a new method enabling the measurement of DNA methylation levels in samples containing only few (oligo) spermatozoa, which we have dubbed OSMA. Samples containing 10 spermatozoa each were collected by micromanipulation and the DNA methylation levels of maternally methylated gene KCNQ1OT1 were evaluated (Fig. 1) . The results show that there is significantly increased variation in the levels of KCNQ1OT1 methylation in some samples with abnormal sperm parameters, as indicated by statistically significantly higher SD values (P = 0.0001; Fig. 1 ), compared with the normozoospermic group.
Sperm of men with abnormal sperm parameters is composed of epigenetically distinguishable sperm populations
To take a deeper look at the heterogeneity observed by OSMA, methylation of two maternally (KCNQ1OT1 and MEST) and two paternally methylated genes (H19 and MEG3) was measured by DBS. In contrast to H19, MEG3 methylation is acquired only after fertilization and therefore is typically unmethylated in sperm (24, 25) . The amplicons target the promoter CpG islands of KCNQ1OT1, MEST and MEG3 as well as the CTCF binding site 6 of the IGF2/H19 imprinting control region (referred throughout as H19). Figure 2 and Table 1 show the sequencing plots for two representative samples and the mean methylation levels of the genes in each of the samples measured by DBS. This method allows the measurement of DNA methylation in individual DNA molecules, corresponding to single-sperm reads. All four genes studied had significantly different DNA methylation levels in the oligoasthenoteratozoospermic (OAT) group (n = 7) compared with the normozoospermic samples (n = 5). The increased variation in KCNQ1OT1 methylation levels previously found by OSMA in OAT samples (Fig. 1) was also detected using DBS.
Normozoospermic sample (Fig. 3 left and Supplementary Material, Fig. S1 ) sequences showed almost completely unmethylated sequences for KCNQ1OT1, MEST and MEG3, and nearly completely methylated sequences for H19. In contrast, the OAT sample sequences (Fig. 3 right) showed a high percentage of aberrantly methylated sequences for each locus investigated. Similar patterns could be found, with varying degrees of severity, in all OAT samples analysed (Supplementary Material, Figs S2 and S3). Interestingly, there was a similar extent of abnormal methylation at the four loci for each individual.
Aberrant DNA methylation of H19 appears to occur preferentially on the maternally inherited allele
In view of the fact that patients had discrete populations of spermatozoa with different methylation patterns, we wished to know whether the epigenetic defects affected the paternal chromosome, the maternal chromosome or both chromosomes. It is possible to answer this question, if the two parental alleles can be distinguished at the DNA level, for example by a single nucleotide polymorphism (SNP) in the differentially methylated region. In this case, the DBS reads can be sorted by SNP allele and analysed separately for the degree of methylation. Due to the inability to obtain DNA samples from the patients' parents for a DNA segregation analysis, we determined the parental origin of each allele by investigating the methylation patterns in blood. Among the individuals analysed, four OAT and two normozoospermic were heterozygous for a common A/T SNP (rs2071094) at the H19 locus ( Fig. 4 and Supplementary Material, Figs S1-S3). Since in somatic tissues H19 is methylated on the paternal chromosome and unmethylated on the maternal one, in these six individuals the alleles could be unambiguously assigned to their parental origin. In the blood of one normozoospermic and three OAT individuals the T allele was unmethylated and therefore of maternal origin. In two individuals, one normozoospermic and one OAT, the A allele was found to be of maternal origin. In the sperm of normozoospermic individuals ( Fig. 4A and Supplementary Material, Fig. S1 ), both alleles were nearly completely methylated, i.e. carried a normal imprint. In the four heterozygous OAT sperm samples ( Fig. 4B and C, and Supplementary Material, Figs S2 and S3) the paternally derived alleles were found to be completely methylated (i.e. had a normal imprint), whereas the maternally derived alleles had a high percentage of unmethylated (i.e. incorrectly imprinted) sequences. Thus, in each of the four OAT cases the maternal chromosome was affected.
Discussion
Previous studies on epimutations in sperm of infertile men and have found an association of abnormal sperm parameters with abnormal methylation of some imprinted genes (11) (12) (13) (14) (15) (16) (17) (18) . However, all these studies used large numbers of spermatozoa and chiefly determined only average CpG methylation levels. In The number of reads is indicated between brackets.
Human Molecular Genetics, 2015, Vol. 24, No. 5 | 1297 order to do more detailed studies on the possible epigenetic heterogeneity of sperm, we used two novel approaches: OSMA and DBS. The use of a very small number of cells analysed here enables the detection of potential heterogeneity by increasing the contribution of each cell to the final DNA methylation measurement. Therefore, we developed OSMA as a novel method enabling the measurement of DNA methylation levels in samples containing only few sperm collected by micromanipulation and used it to evaluate DNA methylation levels of the maternally methylated gene KCNQ1OT1 (Fig. 1) . The number of pooled spermatozoa was empirically determined, 10 being the minimum amount of sperm that could be consistently collected resulting in sufficient amount of DNA for obtaining a polymerase chain reaction (PCR) product. In OSMA, only KCNQ1OT1 was studied, because this assay proved able to reliably amplify and pyrosequence the bisulfite-treated DNA of only 10 spermatozoa. We selected only motile, morphologically normal cells, a scenario that in a clinical setting is being used for assisted reproductive techniques (ART). Even then, there is a larger variation in DNA methylation levels in samples from individuals with abnormal sperm parameters when compared with normozoospermic ones (Fig. 1) . Repeated measurements of DNA methylation levels in the same sample by pyrosequencing have been previously shown to have very little variation (26, 27) . Therefore, the larger variation detected by OSMA in each sample is probably due to the presence of spermatozoa with aberrant KCNQ1OT1 methylation, which caused an increase in the measured average methylation levels of each aliquot. Thus, the initial hypothesis that aberrant methylation levels found in the sperm DNA of some men with abnormal sperm parameters could be caused by epigenetic heterogeneity was confirmed. Although OSMA represents an advance in the epigenetic analysis of sperm, it does not provide base pair resolution data on single spermatozoa. Until recently, the gold standard for single molecule methylation analysis was subcloning of PCR products from bisulfite-treated DNA followed by Sanger sequencing. However, the subcloning step is time consuming and bias-prone, and the small number of clones that can be reasonably analysed prohibits an accurate quantification of methylation levels. DBS circumvents these problems by allowing the parallel analysis of thousands of spermatozoa (28) (29) (30) . In this study, the average number of reads was 2362, which has been previously shown to be sufficient for statistical and biological evaluation (31) .
Swim-up sperm DNA samples were selected for DBS by prescreening for MEST methylation by pyrosequencing (data not shown), which has previously been shown to be associated with sperm quality, and for which a reference range (0-15%) has been established (11) . All measurements were performed using sperm prepared by swim-up, the same used for ART methods such as in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). Samples were divided into two groups (n = 5): normozoospermic with normal MEST methylation (<15%) and OAT samples with aberrant MEST methylation (>15%). For each sample, DBS was performed on four, commonly studied, imprinted genes: KCNQ1OT1, MEST, H19 and MEG3. The mean methylation levels of each gene were significantly different in the OAT group compared with normozoospermic (Fig. 2) . The variation in KCNQ1OT1 methylation levels previously found by OSMA in OAT samples (Fig. 1) was also detected by DBS. Graphical representation of single sequencing reads (Fig. 3 and Supplementary Material, Figs S1-S3) shows that, in normozoospermic samples, CpG sites are homogeneously unmethylated in KCNQ1OT1, MEST and MEG3, and homogeneously methylated in H19. However, in OAT samples two classes of sequences were found: sequences that are methylated at nearly all CpGs and sequences that are unmethylated at nearly all CpGs. Similar patterns were observed for all genes in all samples (Supplementary Material, Figs S2 and S3) but not in blood DNA, which points to a germline-specific defect. These results indicate that aberrant mean Human Molecular Genetics, 2015, Vol. 24, No. 5 | 1299 methylation values in sperm are caused by epigenetic mosaicism in the germline. Nevertheless, as we cannot determine the methylation pattern of multiple loci in the same sperm cell, we do not know whether affected spermatozoa have multiple imprinting defects or if there are different subpopulations of affected spermatozoa with a single imprinting defect at different loci. The highly similar extent of abnormal methylation at the four loci within the same individual, however, suggests that the first assumption might be correct.
In the case of H19, we could demonstrate that the imprinting defect occurred preferentially on the maternal allele. This finding suggests that, even in the absence of DNA methylation, the two alleles retain parent-of-origin specific differences. This is in accordance with previous data obtained from mice showing that the H19 imprint establishment in male mice occurs at different times at the maternal and the paternal allele (5, 6, 8) .
There are several possible explanations to this epigenetic mosaicism in the germline of these patients. The finding of epigenetic mosaicism restricted to the germline of the patients suggests that the imprinting defects occurred after PGCs migrated to the gonadal ridge and began their epigenetic reprogramming. In this case either the maternal imprints failed to be erased in some PGCs, or re-methylation failed in some PGCs after erasure. We also cannot exclude the possibility that some factor caused an alteration in the methylation pattern of these genes at a time unrelated to imprinting re-establishment. Because the aberrant imprints of KCNQ1OT1, MEST and MEG3 present a maternal methylation pattern and the H19 imprinting defect was always on the maternal allele, we believe these defects probably result from a failure in imprinting erasure and reprogramming in a few PGCs (Fig. 5) . Indirect evidence for a failure to erase the maternal imprint during spermatogenesis was obtained in patients with PWS (32) . On the basis of the analysis of DNA polymorphisms and methylation patterns in affected families, Buiting and colleagues found that in each of the 19 patients with a primary imprinting defect analysed (imprinting centre mutation excluded), the aberrantly imprinted chromosome was derived from the paternal grandmother. This suggests that the patient's father inherited a methylated chromosome 15 from his mother and that he passed this chromosome on to his affected child without having erased the maternal methylation imprint in his germline.
The methylation pattern of MEG3 in sperm of OAT individuals makes for an interesting case. These individuals have a significant proportion of spermatozoa with a paternal methylation pattern which, at first glance, looks normal. However, it is important to note that MEG3 is normally unmethylated in sperm. Paternal methylation of MEG3 is a somatic imprint that develops only after fertilization as a result of the action of neighbouring IG-DMR, which carries the germline imprint (24, 25) . The finding of a somatic MEG3 imprint in sperm again points to an imprinting erasure error, this time affecting the paternal allele. Taken together, the data suggest that some cases of infertility might be linked to a general defect in imprint erasure that occurred during the early embryonic life of the patient.
Abnormally completely methylated/unmethylated epialleles of H19 and MEST have been previously detected in studies based on cloning and bisulfite sequencing (14, 17, 33) . However, this observation had not been further explored until now. This is the first time the DNA methylation signature of imprinted genes is described in depth in sperm.
In summary, we were able to demonstrate that the aberrant DNA methylation levels of imprinted genes found by previous studies in the sperm of infertile men are due to the presence of a subpopulation of sperm with incorrect imprints and not due to a random methylation defect at individual CpG dinucleotides. We are aware that it is not easy to distinguish between epigenetic germline mosaicism and the contamination of germ cells with somatic cells. However, we have taken extreme care to prevent such a contamination: spermatozoa were isolated by micromanipulation (OSMA) or swim-up (DBS) techniques, which minimize a contamination. Furthermore, by microscopic inspection the spermatozoa samples looked pure. While traces of somatic DNA cannot be excluded, the finding of highly aberrant patterns as observed in the majority of samples cannot be explained by a contamination.
Our study is limited by the small number of samples used, most of them with very aberrant sperm parameters. Future studies should include a larger number of samples, with milder defects, and additional target genes, including non-imprinted ones. Nevertheless, the co-existence of correctly and aberrantly imprinted sperm in some individuals raises concerns that the use of epimutated sperm for ART might increase the chances of imprinting disorders in the offspring. The selection of correctly methylated sperm has been previously shown to increase the fertilization rates; therefore, the next step should be to find a way to differentiate the 'bad' from the 'good' sperm and to select the correctly methylated spermatozoa in order to increase ART success rates.
Materials and Methods
Experimental overview
Sperm epigenetic heterogeneity was evaluated by two different techniques: OSMA and DBS.
OSMA By micromanipulation, fractions of 10 motile spermatozoa with normal morphology were selected from swim-up purified samples with normal and abnormal sperm parameters. DNA was isolated and treated with sodium bisulfite. DNA methylation levels of maternally methylated gene KCNQ1OT1 were measured by pyrosequencing following PCR. DBS DNA was isolated from swim-up purified spermatozoa from samples with normal and abnormal sperm parameters and treated with sodium bisulfite. DNA methylation levels of maternally imprinted gene MEST were measured by pyrosequencing following PCR. Samples were separated into two groups: (1) normozoospermic with normal (<15%) MEST methylation and (2) OAT with abnormal (>15%) MEST methylation. Libraries for four imprinted genes (KCNQ1OT1, MEST, H19 and MEG3) were constructed by PCR. Amplicons were sequenced using the Roche/454 GS junior system.
Samples
Semen samples were collected from patients attending the Department of Clinical Andrology at the Centre of Reproductive Medicine and Andrology (Münster, Germany). All patients underwent complete physical evaluation and patients with a genetic cause for male infertility were excluded (chromosomal aberrations and azoospermia factor deletions). For each patient semen analysis, including sperm count, motility, and morphology (Table 2) , was performed according to the 2010 World Health Organization (WHO) guidelines. Each sperm sample was prepared by the swim-up procedure (WHO, 2010) . This technique effectively selects the motile spermatozoa from the ejaculate and avoids contamination by other cell types such as somatic cells.
For the analysis of DNA methylation in samples with a reduced amount of sperm cells (OSMA), fractions containing 10 spermatozoa were collected by micromanipulation using a 7 µm diameter, blunt, bent (30°), ICSI glass needle (Biomedical Instruments, Zöllnitz, Germany). Briefly, swim-up sperm was pipetted into sperm preparation medium (Origio, Berlin, Germany) drops under mineral oil (Sage; KB Biosystems, Ulm, Germany) on a Petri dish. Sperm movement was slowed by the addition of 7% polyvinylpyrrolidone (Sage). Morphologically normal, motile sperm (i.e. suitable for IVF) were individually aspirated into the needle and placed in droplets of medium, later transferred to PCR tubes and stored at −20°C until further processing. Contamination during sperm collection by other cells was excluded not only by the visual observation of the cells as they were being collected but also by the inclusion of negative controls in each PCR reaction. Moreover, for each sample at least one aliquot did not contain any sperm, resulting in the absence of any bands following PCR.
Ethical approval
All subjects provided written informed consent and agreed to the analysis of genetic material as approved by the Ethics Committee of the University and the state medical board (reference number of Institutional Review Board approval: 4INie). 
DNA isolation and bisulfite conversion
For OSMA, the DNA of samples containing 10 spermatozoa was isolated and bisulfite-converted using the Epitect Plus kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions with some modifications. Sperm was lysed for 30 min at 56°C in a lysis solution consisting of 15 µl FTB buffer, 5 µl Proteinase K and 20 µl nuclease-free water. For bisulfite treatment, 85 µl of bisulfite solution and 15 µl DNA protect buffer were added to the lysed cell solution, and conversion was carried out according to the protocol supplied by the manufacturer. Bisulfite-treated DNA was purified following the manufacturer's instructions, using carrier RNA to increase the yield of purified DNA. Bisulfite-treated DNA was eluted in 20 µl and stored at −20°C. For DBS, DNA was isolated from swim-up sperm using the MasterPure DNA purification kit (Epicentre Biotechnologies, Madison, WI, USA) with appropriate modifications. Briefly, sperm pellets were re-suspended in 1 ml of a 0.25% solution of Triton X-100 (Sigma-Aldrich, Steinheim, Germany) in phosphate buffered saline (PBS) and incubated for 10 min at room temperature. A pellet was obtained by centrifuging for 10 min at 1520 × g (4°C). Supernatant was discarded and the pellet was re-dissolved in 1 ml of 25 mm dithiothreitol solution in PBS, followed by incubation on ice for 15 min to de-condense the DNA. A pellet was obtained by centrifuging the tubes at 1520 × g for 10 min (4°C). Supernatant was discarded, the pellet was re-suspended in 300 µl tissue and cell lysis buffer and 2 µl Proteinase K and incubated for 30 min at 56°C followed by 5 min on ice. Two hundred microliters of MCP precipitation reagent were added and contents were mixed by vortexing for 10 s. Proteins were removed by centrifugation at 16 060 × g for 15 min (12°C). The supernatant was transferred to a fresh microcentrifuge tube and 500 µl isopropanol were added and mixed by inversion. After 2 h incubation at −20°C the precipitated DNA was pelleted by centrifuging for 20 min at 16 060 × g (4°C). The DNA pellet was further washed with ice-cold 75% ethanol and ultimately dissolved in 20 µl TE buffer. When available, genomic DNA was isolated from ethylenediaminetetraacetic acid blood using the FlexiGene DNA kit (Qiagen) according to the manufacturer's instructions. DNA concentration was measured using the NanoDrop ND-1000 spectrophotometer (Peqlab, Erlangen, Germany). Two hundred nanograms of DNA were bisulfite treated using the EZ DNA Methylation-Gold kit (Zymo Research, Freiburg, Germany) according to the manufacturer's protocol, eluting the DNA in 10 µl.
Pyrosequencing
Primers specific for the amplification and pyrosequencing (Table 3) of CpG sites in the regulatory regions of maternally methylated genes KCNQ1OT1 and MEST have been previously published (11) . The amplification mixture (20 µl) consisted of 5 µl sterile water, 10 µl of 10× PyroMark PCR Master Mix (Qiagen), 1 µl each primer (20 pmol/µl; Eurofins MWG, Ebersberg, Germany) and 3 µl of bisulfite-treated DNA template. The presence of a product after PCR was analysed by agarose gel electrophoresis. Sequencing results were analysed using PyroMark Q24 v2.0.6 software (QIAGEN).
Deep bisulfite sequencing
Locus-specific bisulfite amplicon libraries were constructed using tagged primers (Table 3) and HotStarTaq Master Mix (Qiagen). Sample-specific barcode sequences (MID, multiplex identifiers) and universal linker tags (454 adaptor sequences) were added by a second PCR [95°C, 15 min; 35× (95°C, 30 s; 72°C, 1 min), 72°C, 10 min]. Sample preparation and sequencing using the Roche/454 GS junior system (Roche Diagnostics, Manheim, Germany) was performed as previously described (30) . To increase the yield of reads for data analysis, special filter settings were applied (29) .
Methylation analysis was performed using the Amplikyzer software (34) . Only reads with a conversion rate over 95% were used for the analysis, leading to an average of 2362 reads per sample. The number of reads and the mean methylation across all CpGs are given per sample and per amplicon. In the case of H19, the presence of an A/T SNP (rs2071094) enabled the allelic separation of the sequencing reads (i.e. allele A-containing reads could be analysed and graphically depicted separately from T-containing reads). 
Statistical analysis
Comparison of sperm parameters between groups was done by two-way ANOVA. Significant differences in SD values were tested using Bartlett's test for equal variances after Log 10 transformation. Comparison of DNA methylation levels between groups was done using the Kruskal-Wallis test followed by Dunn's multiple comparison test (OSMA) or two-way ANOVA followed by the Bonferroni post hoc test (DBS), both with a 95% confidence level. All statistical calculations were performed using GraphPad Prism software v5.00 (GraphPad Software, San Diego, CA, USA). Experimental data are presented as mean ± SEM unless stated otherwise.
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